URMC / Labs / Barnas Lab / Publications

Publications

1. Nozaki Y
2. Hao Y
3. Barnas JL
Editorial: Treat-to-target in systemic lupus erythematosus: cytokine transduction pathways in SLE.; Frontiers in immunology; Vol 15, pp. 1503776. 2024 Oct 16.
1. Sakaue S
2. Weinand K
3. Isaac S
4. Dey KK
5. Jagadeesh K
6. Kanai M
7. Watts GFM
8. Zhu Z
9. Brenner MB
10. McDavid A
11. Donlin LT
12. Wei K
13. Price AL
14. Raychaudhuri S
Tissue-specific enhancer-gene maps from multimodal single-cell data identify causal disease alleles.; Nature genetics. 2024 Apr 09.
1. Carlucci PM
2. Preisinger K
3. Deonaraine KK
4. Zaminski D
5. Dall'Era M
6. Gold HT
7. Kalunian K
8. Fava A
9. Belmont HM
10. Wu M
11. Putterman C
12. Anolik J
13. Barnas JL
14. Furie R
15. Diamond B
16. Davidson A
17. Wofsy D
18. Kamen D
19. James JA
20. Guthridge JM
21. Apruzzese W
22. Rao D
23. Weisman MH
24. Izmirly PM
25. Buyon J
26. Petri M
Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network.; Rheumatology (Oxford, England). 2024 Mar 26.
1. Izmirly PM
2. Kim MY
3. Carlucci PM
4. Preisinger K
5. Cohen BZ
6. Deonaraine K
7. Zaminski D
8. Dall'Era M
9. Kalunian K
10. Fava A
11. Belmont HM
12. Wu M
13. Putterman C
14. Anolik J
15. Barnas JL
16. Diamond B
17. Davidson A
18. Wofsy D
19. Kamen D
20. James JA
21. Guthridge JM
22. Apruzzese W
23. Rao DA
24. Weisman MH
25. Petri M
26. Buyon J
27. Furie R
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network.; Arthritis research & therapy; Vol 26(1), pp. 54. 2024 Feb 20.
1. Fava A
2. Buyon J
3. Magder L
4. Hodgin J
5. Rosenberg A
6. Demeke DS
7. Rao DA
8. Arazi A
9. Celia AI
10. Putterman C
11. Anolik JH
12. Barnas J
13. Dall'Era M
14. Wofsy D
15. Furie R
16. Kamen D
17. Kalunian K
18. James JA
19. Guthridge J
20. Atta MG
21. Monroy Trujillo J
22. Fine D
23. Clancy R
24. Belmont HM
25. Izmirly P
26. Apruzzese W
27. Goldman D
28. Berthier CC
29. Hoover P
30. Hacohen N
31. Raychaudhuri S
32. Davidson A
33. Diamond B
34. Petri M
Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis.; JCI insight; Vol 9(2). 2024 Jan 23.
1. Horisberger A
2. Griffith A
3. Keegan J
4. Arazi A
5. Pulford J
6. Murzin E
7. Howard K
8. Hancock B
9. Fava A
10. Sasaki T
11. Ghosh T
12. Inamo J
13. Beuschel R
14. Cao Y
15. Preisinger K
16. Gutierrez-Arcelus M
17. Eisenhaure TM
18. Guthridge J
19. Hoover PJ
20. Dall'Era M
21. Wofsy D
22. Kamen DL
23. Kalunian KC
24. Furie R
25. Belmont M
26. Izmirly P
27. Clancy R
28. Hildeman D
29. Woodle ES
30. Apruzzese W
31. McMahon MA
32. Grossman J
33. Barnas JL
34. Payan-Schober F
35. Ishimori M
36. Weisman M
37. Kretzler M
38. Berthier CC
39. Hodgin JB
40. Demeke DS
41. Putterman C
42. Brenner MB
43. Anolik JH
44. Raychaudhuri S
45. Hacohen N
46. James JA
47. Davidson A
48. Petri MA
49. Buyon JP
50. Diamond B
51. Zhang F
52. Lederer JA
53. Rao DA
Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis.; bioRxiv : the preprint server for biology. 2024 Jan 15.
1. Zhang F
2. Jonsson AH
3. Nathan A
4. Millard N
5. Curtis M
6. Xiao Q
7. Gutierrez-Arcelus M
8. Apruzzese W
9. Watts GFM
10. Weisenfeld D
11. Nayar S
12. Rangel-Moreno J
13. Meednu N
14. Marks KE
15. Mantel I
16. Kang JB
17. Rumker L
18. Mears J
19. Slowikowski K
20. Weinand K
21. Orange DE
22. Geraldino-Pardilla L
23. Deane KD
24. Tabechian D
25. Ceponis A
26. Firestein GS
27. Maybury M
28. Sahbudin I
29. Ben-Artzi A
30. Mandelin AM
31. Nerviani A
32. Lewis MJ
33. Rivellese F
34. Pitzalis C
35. Hughes LB
36. Horowitz D
37. DiCarlo E
38. Gravallese EM
39. Boyce BF
40. Moreland LW
41. Goodman SM
42. Perlman H
43. Holers VM
44. Liao KP
45. Filer A
46. Bykerk VP
47. Wei K
48. Rao DA
49. Donlin LT
50. Anolik JH
51. Brenner MB
52. Raychaudhuri S
Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes.; Nature; Vol 623(7987), pp. 616-624. 2023 Nov 08.
1. Carlucci PM
2. Li J
3. Fava A
4. Deonaraine KK
5. Wofsy D
6. James JA
7. Putterman C
8. Diamond B
9. Davidson A
10. Fine DM
11. Monroy-Trujillo J
12. Atta MG
13. DeJager W
14. Guthridge JM
15. Haag K
16. Rao DA
17. Brenner MB
18. Lederer JA
19. Apruzzese W
20. Belmont HM
21. Izmirly PM
22. Zaminski D
23. Wu M
24. Connery S
25. Payan-Schober F
26. Furie R
27. Dall'Era M
28. Cho K
29. Kamen D
30. Kalunian K
31. Anolik J
32. Barnas J
33. Ishimori M
34. Weisman MH
35. Buyon JP
36. Petri M
High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines Partnership.; Rheumatology (Oxford, England). 2022 Feb 25.
1. Carlucci P
2. Li J
3. Fava A
4. Deonaraine K
5. Wofsy D
6. James J
7. Putterman C
8. Diamond B
9. Davidson A
10. Fine D
11. Monroy-Trujillo J
12. Atta M
13. DeJager W
14. Guthridge J
15. Haag K
16. Rao D
17. Bernner M
18. Lederer J
19. Apruzzese W
20. Belmont M
21. Izmirly P
22. Wu M
23. Connery S
24. Payan-Schober F
25. Furie R
26. Dall'Era M
27. Cho K
28. Kamen D
29. Kalunian K
30. Anolik J
31. Barnas J
32. Ishimori M
33. Weisman M
34. Buyon J
35. Petri M
High incidence of clinically actionable kidney histology in SLE patients with low proteinuria in the Accelerating Medicines Partnership; Rheumatology; Vol (accepted). 2022 Jan 01.
1. Barnas JL
2. Albrecht J
3. Meednu N
4. Alzamareh DF
5. Baker C
6. McDavid A
7. Looney RJ
8. Anolik JH
B Cell Activation and Plasma Cell Differentiation Are Promoted by IFN-λ in Systemic Lupus Erythematosus.; Journal of immunology (Baltimore, Md. : 1950). 2021 Oct 27.
1. Deonaraine KK
2. Carlucci PM
3. Fava A
4. Li J
5. Wofsy D
6. James JA
7. Putterman C
8. Diamond B
9. Davidson A
10. Fine DM
11. Monroy-Trujillo J
12. Atta MG
13. Haag K
14. Rao DA
15. Apruzzese W
16. Belmont HM
17. Izmirly PM
18. Wu M
19. Connery S
20. Payan-Schober F
21. Furie RA
22. Berthier CC
23. Dall'Era M
24. Cho K
25. Kamen DL
26. Kalunian K
27. Anolik J
28. Ishimori M
29. Weisman MH
30. Petri MA
31. Buyon JP
Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE Network.; Lupus science & medicine; Vol 8(1). 2021 Aug.
1. Barnas JL
2. Looney RJ
3. Anolik JH
B cell targeted therapies in autoimmune disease.; Current opinion in immunology; Vol 61. 2019 Dec.
1. Dieudonné Y
2. Gies V
3. Guffroy A
4. Keime C
5. Bird AK
6. Liesveld J
7. Barnas JL
8. Poindron V
9. Douiri N
10. Soulas-Sprauel P
11. Martin T
12. Meffre E
13. Anolik JH
14. Korganow AS
Transitional B cells in quiescent SLE: An early checkpoint imprinted by IFN.; Journal of autoimmunity; Vol 102. 2019 Aug.
1. Gao L
2. Slack M
3. Barnas JL
4. McDavid A
5. Anolik J
6. Looney RJ
Correction to: Cell Senescence in Lupus.; Current rheumatology reports; Vol 21(7). 2019 May 23.
1. Barnas JL
2. Ritchlin CT
Etiology and Pathogenesis of Psoriatic Arthritis.; Rheumatic diseases clinics of North America; Vol 41(4). 2015 Nov.
1. Simpson-Abelson MR
2. Loyall JL
3. Lehman HK
4. Barnas JL
5. Minderman H
6. O'Loughlin KL
7. Wallace PK
8. George TC
9. Peng P
10. Kelleher RJ
11. Odunsi K
12. Bankert RB
Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cells.; Cancer immunity; Vol 13. 2013.
1. Bankert RB
2. Balu-Iyer SV
3. Odunsi K
4. Shultz LD
5. Kelleher RJ
6. Barnas JL
7. Simpson-Abelson M
8. Parsons R
9. Yokota SJ
Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis.; PloS one; Vol 6(9). 2011.
1. Mulhall JP
2. Barnas J
3. Kobylarz K
4. Mueller A
p53-Associated Parkin-like cytoplasmic protein (Parc) short-interfering RNA (siRNA) alters p53 location and biology of Peyronie's disease fibroblasts.; BJU international; Vol 106(11). 2010 Dec.
1. Barnas JL
2. Simpson-Abelson MR
3. Brooks SP
4. Kelleher RJ
5. Bankert RB
Reciprocal functional modulation of the activation of T lymphocytes and fibroblasts derived from human solid tumors.; Journal of immunology (Baltimore, Md. : 1950); Vol 185(5). 2010 Sep 01.
1. Barnas JL
2. Simpson-Abelson MR
3. Yokota SJ
4. Kelleher RJ
5. Bankert RB
T cells and stromal fibroblasts in human tumor microenvironments represent potential therapeutic targets.; Cancer microenvironment : official journal of the International Cancer Microenvironment Society; Vol 3(1). 2010 Mar 31.
1. Mulhall J
2. Teloken P
3. Barnas J
Vasculogenic erectile dysfunction is a predictor of abnormal stress echocardiography.; The journal of sexual medicine; Vol 6(3). 2009 Mar.
1. Barnas J
2. Parker M
3. Guhring P
4. Mulhall JP
The utility of tamsulosin in the management of orgasm-associated pain: a pilot analysis.; European urology; Vol 47(3). 2005 Mar.
1. Brooks MB
2. Barnas JL
3. Fremont J
4. Ray J
Cosegregation of a factor VIII microsatellite marker with mild hemophilia A in Golden Retriever dogs.; Journal of veterinary internal medicine; Vol 19(2). 2005 Mar.
1. Mulhall J
2. Barnas J
3. Aviv N
4. Anderson M
5. Parker M
Sildenafil citrate response correlates with the nature and the severity of penile vascular insufficiency.; The journal of sexual medicine; Vol 2(1). 2005 Jan.
1. Barnas JL
2. Pierpaoli S
3. Ladd P
4. Valenzuela R
5. Aviv N
6. Parker M
7. Waters WB
8. Flanigan RC
9. Mulhall JP
The prevalence and nature of orgasmic dysfunction after radical prostatectomy.; BJU international; Vol 94(4). 2004 Sep.
1. Brooks MB
2. Gu W
3. Barnas JL
4. Ray J
5. Ray K
A Line 1 insertion in the Factor IX gene segregates with mild hemophilia B in dogs.; Mammalian genome : official journal of the International Mammalian Genome Society; Vol 14(11). 2003 Nov.